SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600620-23-000012
Filing Date
2023-05-04
Accepted
2023-05-04 06:10:50
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20230331.htm   iXBRL 10-Q 1059994
2 EX-31.1 auph-2023q1exx311.htm EX-31.1 10968
3 EX-31.2 auph-2023q1exx312.htm EX-31.2 11110
4 EX-32.1 auph-2023q1exx321.htm EX-32.1 5436
5 EX-32.2 auph-2023q1exx322.htm EX-32.2 5444
  Complete submission text file 0001600620-23-000012.txt   5617441

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20230331.xsd EX-101.SCH 38165
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20230331_cal.xml EX-101.CAL 63103
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20230331_def.xml EX-101.DEF 145041
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20230331_lab.xml EX-101.LAB 483536
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20230331_pre.xml EX-101.PRE 307408
70 EXTRACTED XBRL INSTANCE DOCUMENT auph-20230331_htm.xml XML 954728
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 23886246
SIC: 2834 Pharmaceutical Preparations